170 results
Page 5 of 9
6-K
EX-99.1
y30uhegyjme jmty2hkd
18 Feb 21
Enlivex Announces Exercise of Underwriter’s Option to Purchase Additional Shares
8:03am
6-K
EX-99.1
4okjig
16 Feb 21
Current report (foreign)
8:30am
6-K
EX-99.1
iii7qji4uatze2lcf7j
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-1.1
4essn1b
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
pshpd0siwrxqsu90luq
10 Feb 21
Prospectus supplement for primary offering
5:22pm
FWP
clytmnhi1 wlh30p1
10 Feb 21
Free writing prospectus
6:08am
FWP
ob0xw ke915c
9 Feb 21
Free writing prospectus
5:21pm
424B5
sv1t55emzpmj
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-99.1
se7bw0xj
3 Feb 21
Current Report
7:55am
6-K
EX-99.1
paqwc5u0 g71s3xoqf
21 Dec 20
Enlivex Announces Pre-Print Publication of Full Results from Phase Ib Severe Sepsis Trial on medRxiv
8:02am
6-K
EX-99.1
e7xso shjo0zvdhpolhg
7 Dec 20
Enlivex Announces Issuance of New Chinese Patent Covering Allocetra Immunotherapy
8:02am
6-K
EX-99.1
v4r3s5r
3 Dec 20
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:00am
6-K
EX-99.1
qfbqoeazib5xk
18 Nov 20
Enlivex Reports Positive Two-Year Clinical Outcome For A Hospitalized Patient with Erosive Osteoarthritis Treated with Allocetra
8:02am
6-K
EX-99.1
t8p8uin9ezkaz0
17 Nov 20
Enlivex Appoints Former ArQule, Inc. Executive Dr. Brian Schwartz to the Company’s Board of Directors
8:18am
6-K
EX-99.1
4cilxrdi5k2nq9sm
12 Nov 20
Enlivex to Present Schedule for Sepsis, COVID-19 and Solid Cancer Programs at H.C. Wainwright’s 6th Annual Israel Conference
8:01am
6-K
EX-99.1
2ws84abot5rrdg28
3 Nov 20
Current report (foreign)
9:14am
6-K
EX-99.2
qpwob
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
c95azdmjxeka zy
27 Oct 20
Report of Foreign Private Issuer
8:03am
6-K
EX-99.1
0h43ze5u 10
22 Oct 20
Enlivex Reports Dosing of First Two Patients in Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
8:49am
6-K
EX-10.1
kabtebhgafx zar
22 Oct 20
Report of Foreign Private Issuer
8:47am